05:44 PM EDT, 08/02/2024 (MT Newswires) -- Mark A Goldsmith, Director, President and Chief Executive Officer, on August 01, 2024, sold 10,000 shares in Revolution Medicines ( RVMD ) for $458,827. Following the Form 4 filing with the SEC, Goldsmith has control over a total of 828,337 shares of the company, with 311,885 shares held directly and 516,452 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1628171/000161071724000411/xslF345X03/form4.xml

Price: 44.01, Change: +0.01, Percent Change: +0.02